"Klinik für Gynäkologie mit Zentrum für onkologische Chirurgie"

During the past decade, Campus Virchow-Klinikum Charité; Centrum 17; Klinik für Gynäkologie conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 2 clinical trials were completed, i.e. on average, 66.7% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 1 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Campus Virchow-Klinikum Charité; Centrum 17; Klinik für Gynäkologie" #1 collaborator was "ARCAGY/ GINECO GROUP" with 1 trials as a collaborator, "Cancer Research UK" with 1 trials as a collaborator, "European Network of Gynaecological Oncological Trial Groups (ENGOT)" with 1 trials as a collaborator, "GOG Foundation" with 1 trials as a collaborator and "Grupo Español de Investigación en Cáncer de Ovario" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 6 trials.

According to Clinical.Site data, the most researched conditions in "Campus Virchow-Klinikum Charité; Centrum 17; Klinik für Gynäkologie" are "Ovarian Cancer" (5 trials), "Fallopian Tube Cancer" (2 trials), "Epithelial Ovarian Cancer" (1 trials), "Peritoneal Cavity Cancer" (1 trials) and "Peritoneal Neoplasms" (1 trials). Many other conditions were trialed in "Campus Virchow-Klinikum Charité; Centrum 17; Klinik für Gynäkologie" in a lesser frequency.

Most popular intervention types in "Campus Virchow-Klinikum Charité; Centrum 17; Klinik für Gynäkologie" are "Drug" (5 trials), "Procedure" (2 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Bevacizumab" (2 trials), "Paclitaxel" (2 trials), "3 cycles of standard chemotherapy" (1 trials), "6 cycles of standard chemotherapy" (1 trials) and "Atezolizumab" (1 trials). Other intervention names were less common.

The vast majority of trials in "Campus Virchow-Klinikum Charité; Centrum 17; Klinik für Gynäkologie" are 6 trials for "Female" genders.

Currently, there are NaN active trials in "Campus Virchow-Klinikum Charité; Centrum 17; Klinik für Gynäkologie". undefined are not yet recruiting, undefined are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Campus Virchow-Klinikum Charité; Centrum 17; Klinik für Gynäkologie, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Campus Virchow-Klinikum Charité; Centrum 17; Klinik für Gynäkologie, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".